Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02805712 · ClinicalTrials.gov registry record · NA

Focused Palliative Care Intervention in Advanced Heart Failure

A NA study of Heart Failure and Quality of Life, sponsored by Brigham and Women's Hospital.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT02805712 is a NA study of Heart Failure and Quality of Life that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 50 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02805712, a NA study of Heart Failure and Quality of Life, has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This small pilot study will be assessing the the impact of a standardized, social-worker led, longitudinal palliative care intervention on alignment of patient and physician understanding of prognosis and goals of care. Secondary objectives include assessing the impact of this intervention on documentation of advanced care planning and end of life preferences, symptom burden, quality of life and health care utilization.

Interventions

  • OTHER Control
  • OTHER Verbal Information and Discussion

Study Locations (1)

Massachusetts

  • Brigham and Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2014-09
Est. Completion 2016-12-01
Phase NA

Sponsor

Brigham and Women's Hospital

937 total trials

What the Registry Record Tells You About NCT02805712

The ClinicalTrials.gov registry entry for NCT02805712 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (98% lower). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.

NCT02805712 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02805712 about?

NCT02805712 is a clinical study titled "Focused Palliative Care Intervention in Advanced Heart Failure". This small pilot study will be assessing the the impact of a standardized, social-worker led, longitudinal palliative care intervention on alignment of patient and physician understanding of prognosis and goals of care. Secondary objectives include assessing the impact of this intervention on docume...

What is the current status of trial NCT02805712?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2014-09. Estimated completion is 2016-12-01.

What conditions does trial NCT02805712 study?

This clinical trial studies the following conditions: Heart Failure, Quality of Life.

What interventions are being tested in trial NCT02805712?

The interventions under investigation include: Control (OTHER), Verbal Information and Discussion (OTHER).

Who is sponsoring clinical trial NCT02805712?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02805712 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.